Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Accounts Payables (2020 - 2025)

Definitive Healthcare's Accounts Payables history spans 6 years, with the latest figure at $3.6 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 66.59% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, down 66.59%, while the annual FY2025 figure was $3.6 million, 66.59% down from the prior year.
  • Accounts Payables reached $3.6 million in Q4 2025 per DH's latest filing, down from $8.6 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $10.8 million in Q4 2024 to a low of $3.6 million in Q4 2025.
  • Average Accounts Payables over 5 years is $6.6 million, with a median of $6.1 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: soared 85.99% in 2024, then crashed 66.59% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $4.7 million in 2021, then dropped by 15.12% to $3.9 million in 2022, then surged by 46.58% to $5.8 million in 2023, then soared by 85.99% to $10.8 million in 2024, then plummeted by 66.59% to $3.6 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Accounts Payables are $3.6 million (Q4 2025), $8.6 million (Q3 2025), and $7.9 million (Q2 2025).